174 related articles for article (PubMed ID: 20509816)
1. Photodynamic therapy with intradermal administration of 5-aminolevulinic acid for port-wine stains.
Li W; Yamada I; Masumoto K; Ueda Y; Hashimoto K
J Dermatolog Treat; 2010 Jul; 21(4):232-9. PubMed ID: 20509816
[TBL] [Abstract][Full Text] [Related]
2. Can red-light 5-aminolevulinic photodynamic therapy cure port wine stains on comb animal model?
Lai Y; Zhang H; Wei M; Ji J; Shi L; Wang P; Wang B; Huang Z; Wang X
Photodiagnosis Photodyn Ther; 2018 Jun; 22():253-262. PubMed ID: 29738816
[TBL] [Abstract][Full Text] [Related]
3. Intracutaneous ALA photodynamic therapy: dose-dependent targeting of skin structures.
Sakamoto FH; Doukas AG; Farinelli WA; Tannous Z; Su Y; Smith NA; Zurakowski D; Anderson RR
Lasers Surg Med; 2011 Sep; 43(7):621-31. PubMed ID: 22057490
[TBL] [Abstract][Full Text] [Related]
4. The monitoring of the accumulation of protoporphyrin IX in Walker tumours by subcutaneous administration of delta-aminolevulinic acid.
Calin MA; Gruia Ml; Herascu N; Coman T
J Exp Ther Oncol; 2004 Oct; 4(3):247-51. PubMed ID: 15724844
[TBL] [Abstract][Full Text] [Related]
5. In vitro/in vivo correlations between transdermal delivery of 5-aminolaevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation.
Tsai JC; Chen IH; Wong TW; Lo YL
Br J Dermatol; 2002 May; 146(5):853-62. PubMed ID: 12000384
[TBL] [Abstract][Full Text] [Related]
6. The fluorescence biodistribution and kinetics of aminolevulinic acid induced protoporphyrin IX in the bladder of a rat model with orthotopic urothelial carcinoma.
Gronlund-Pakkanen S; Wahlfors J; Makinen K; Pakkanen TM; Talja M; Ala-Opas M; Alhava E; Moore RB
J Urol; 2002 Apr; 167(4):1848-53. PubMed ID: 11912446
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence kinetics of protoporphyrin-IX induced from 5-ALA compounds in rabbit postballoon injury model for ALA-photoangioplasty.
Kwon OC; Yoon HJ; Kim KH; Kim HT; Yoon YH; Kim JK
Photochem Photobiol; 2008; 84(5):1209-14. PubMed ID: 18363621
[TBL] [Abstract][Full Text] [Related]
8. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser.
Shen SC; Lee WR; Fang YP; Hu CH; Fang JY
J Pharm Sci; 2006 Apr; 95(4):929-38. PubMed ID: 16493590
[TBL] [Abstract][Full Text] [Related]
9. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy.
Loh CS; MacRobert AJ; Bedwell J; Regula J; Krasner N; Bown SG
Br J Cancer; 1993 Jul; 68(1):41-51. PubMed ID: 8318419
[TBL] [Abstract][Full Text] [Related]
10. Clearance mechanism of protoporphyrin IX from mouse skin after application of 5-aminolevulinic acid.
Juzeniene A; Iani V; Moan J
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):538-45. PubMed ID: 24284108
[TBL] [Abstract][Full Text] [Related]
11. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
[TBL] [Abstract][Full Text] [Related]
12. Topical delivery of 5-aminolevulinic acid-encapsulated ethosomes in a hyperproliferative skin animal model using the CLSM technique to evaluate the penetration behavior.
Fang YP; Huang YB; Wu PC; Tsai YH
Eur J Pharm Biopharm; 2009 Nov; 73(3):391-8. PubMed ID: 19660544
[TBL] [Abstract][Full Text] [Related]
13. Retained topical delivery of 5-aminolevulinic acid using cationic ultradeformable liposomes for photodynamic therapy.
Oh EK; Jin SE; Kim JK; Park JS; Park Y; Kim CK
Eur J Pharm Sci; 2011 Sep; 44(1-2):149-57. PubMed ID: 21782942
[TBL] [Abstract][Full Text] [Related]
14. Targeting of sebaceous glands by δ-aminolevulinic acid-based photodynamic therapy: An in vivo study.
Kosaka S; Miyoshi N; Akilov OE; Hasan T; Kawana S
Lasers Surg Med; 2011 Jul; 43(5):376-81. PubMed ID: 21674542
[TBL] [Abstract][Full Text] [Related]
15. Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification.
Tyrrell J; Campbell SM; Curnow A
Photodiagnosis Photodyn Ther; 2011 Mar; 8(1):30-8. PubMed ID: 21333932
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses.
Fauteck JD; Ackermann G; Birkel M; Breuer M; Moor AC; Ebeling A; Ortland C
Arch Dermatol Res; 2008 Feb; 300(2):53-60. PubMed ID: 17960406
[TBL] [Abstract][Full Text] [Related]
17. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study.
Lange N; Jichlinski P; Zellweger M; Forrer M; Marti A; Guillou L; Kucera P; Wagnières G; van den Bergh H
Br J Cancer; 1999 Apr; 80(1-2):185-93. PubMed ID: 10389995
[TBL] [Abstract][Full Text] [Related]
18. The effects of protoporphyrin IX-induced photodynamic therapy with and without iron chelation on human squamous carcinoma cells cultured under normoxic, hypoxic and hyperoxic conditions.
Blake E; Allen J; Curnow A
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):575-82. PubMed ID: 24284114
[TBL] [Abstract][Full Text] [Related]
19. 5-Aminolaevulinic acid-induced protoporphyrin IX accumulation in tissues: pharmacokinetics after oral or intravenous administration.
van den Boogert J; van Hillegersberg R; de Rooij FW; de Bruin RW; Edixhoven-Bosdijk A; Houtsmuller AB; Siersema PD; Wilson JH; Tilanus HW
J Photochem Photobiol B; 1998 Jun; 44(1):29-38. PubMed ID: 9745726
[TBL] [Abstract][Full Text] [Related]
20. Oral aminolevulinic acid induces protoporphyrin IX fluorescence in psoriatic plaques and peripheral blood cells.
Bissonnette R; Zeng H; McLean DI; Korbelik M; Lui H
Photochem Photobiol; 2001 Aug; 74(2):339-45. PubMed ID: 11547574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]